跳至主要内容
临床试验/NCT05728528
NCT05728528已完成4 期

Impact of Moderate to Vigorous-intensity Physical Activities on Pharmacokinetic-guided Extended Half-life FVIII Concentrates Prophylaxis Severe Hemophilia A Patients

Chulalongkorn University1 个研究点 分布在 1 个国家目标入组 13 人开始时间: 2022年7月1日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
已完成
入组人数
13
试验地点
1
主要终点
hemophilia Joint Health Scores (HJHS)

研究概览

简要总结

To compare clinical outcomes before and after using combination between moderate to vigorous-intensity physical activities and pharmacokinetic-guided extended half-life FVIII concentrates prophylaxis in moderate to severe hemophilia A patients

详细描述

This is a prospective cohort study of severe hemophilia A patients receiving low-dose EHL FVIII concentrates with PK-guided EHL FVIII concentrates prophylaxis alone for 6 months. Additional exercise workshops from sport scientists were introduced individually to this group of patients along with using the same prophylaxis method for another period of 6 months. The annualized bleeding rates (ABR), the annualized joint bleeding rates (AJBR), the haemophilia-specific quality-of-life (Haemo-QoL-A) scores, the hemophilia Joint Health Scores (HJHS) and skeletal muscle mass were compared between these two periods

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Parallel
主要目的
Supportive Care
盲法
None

入排标准

性别
Male
接受健康志愿者

入选标准

  • Severe Hemophilia A patients

排除标准

  • 未提供

研究组 & 干预措施

PK-guided EHL FVIII concentrates prophylaxis with moderate intensity physical activities

Experimental

PK-guided EHL FVIII concentrates prophylaxis with moderate intensity physical activities

干预措施: combination between moderate to vigorous-intensity physical activities and pharmacokinetic-guided extended half-life FVIII concentrates prophylaxis (Drug)

PK-guided EHL FVIII concentrates prophylaxis alone

Active Comparator

PK-guided EHL FVIII concentrates prophylaxis alone

干预措施: pharmacokinetic-guided extended half-life FVIII concentrates prophylaxis alone (Drug)

结局指标

主要结局

hemophilia Joint Health Scores (HJHS)

时间窗: 6 months

hemophilia Joint Health Scores (HJHS)

annualized bleeding rates (ABR)

时间窗: 6 months

annualized bleeding rates (ABR)

annualized joint bleeding rates (AJBR)

时间窗: 6 months

annualized joint bleeding rates (AJBR)

haemophilia-specific quality-of-life (Haemo-QoL-A) scores

时间窗: 6 months

haemophilia-specific quality-of-life (Haemo-QoL-A) scores

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Darintr Sosothikul

Associate Professor, Head of Integrative and Innovative Hematology/Oncology Research Unit at Faculty of Medicine, Chulalongkorn University.

Chulalongkorn University

研究点 (1)

Loading locations...

相似试验